{"schema_version":"secwatch.filing_event.v1","accession":"0001104659-26-099712","form_type":"8-K","ticker":"NVCT","cik":"0001875558","company_name":"Nuvectis Pharma, Inc.","filed_at":"2026-08-21T20:31:12+00:00","discovered_at":"2026-08-21T20:32:02.534957+00:00","generated_at":"2026-08-21T20:32:29.272834+00:00","sec_items":["8.01","9.01"],"event_type":"other_material","sentiment":"neutral","materiality_score":0.75,"calibrated_materiality_score":0.75,"confidence":"high","headline":"Nuvectis Pharma establishes new $200M ATM offering program with Jefferies","bullets":["Entered Open Market Sale Agreement with Jefferies LLC on Aug 21, 2026, for up to $200M in common stock.","Sales made via new Form S-3 shelf registration filed Aug 21, 2026; Jefferies fee up to 3.0% of gross proceeds.","Prior ATM program terminated July 20, 2026; no further sales under the Feb 13, 2026 prospectus supplement.","No minimum sales required; proceeds used for general corporate purposes, if any shares are sold."],"urls":{"canonical":"https://secwatch.observer/filing/0001104659-26-099712","json":"https://secwatch.observer/filing/0001104659-26-099712.json","markdown":"https://secwatch.observer/filing/0001104659-26-099712.md","text":"https://secwatch.observer/filing/0001104659-26-099712.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1875558/000110465926099712/0001104659-26-099712-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1875558/000110465926099712/tm2623689d1_8k.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-08-21T20:32:29.272834+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}